2021-11-08T15:50:40-06:00 2020-12-31 390919055 RITZ HOLMAN LLP 330 E KILBOURN AVE SUITE 550 MILWAUKEE WI 53202 990 2020-01-01 237181863 SCOLIOSIS RESEARCH SOCIETY SCOL 4142899107 555 EAST WELLS STREET NO 1100 MILWAUKEE WI 53202 SERENA S HU MD TREASURER 4142899107 2021-11-08 1 SERENA HU MD 999009999 KATY L SOMMER P00273273 4142711451 2021-11-08 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z MUHARREM YAZICI MD 555 E WELLS STREET STE 1100 MILWAUKEE WI 53202 3250108 0 X WWW.SRS.ORG X 1966 IL THE PURPOSE OF THE SCOLIOSIS RESEARCH SOCIETY IS TO FOSTER THE OPTIMAL CARE OF ALL PATIENTS WITH SPINAL DEFORMITIES. 18 17 0 18 8250 6261 1935226 1267676 3179028 1169229 457578 702511 271088 110692 5842920 3250108 1029912 678213 0 0 40000 0 0 0 0 4052608 2065823 5122520 2744036 720400 506072 15810968 17367746 384468 401546 15426500 16966200 X THE PURPOSE OF THE SCOLIOSIS RESEARCH SOCIETY IS TO FOSTER THE OPTIMAL CARE OF ALL PATIENTS WITH SPINAL DEFORMITIES. 1 0 401919 70 59200 IMAST (INTERNATIONAL MEETING ON ADVANCED SPINE TECHNIQUES) PROVIDES AN INTERNATIONAL SCIENTIFIC FORUM FOR SPINE PROFESSIONALS TO STAY UP-TO-DATE ON EMERGING NEW TECHNOLOGIES AND TECHNIQUES. SPINE SURGEONS AND OTHER ALLIED HEALTH PROFESSIONAL FROM AROUND THE WORLD DISCUSS, DEBATE, AND DEMONSTRATE RECENT ADVANCES IN SPINE SURGERY. 491729 2092 459377 THE ANNUAL MEETING AND COURSE IS A FORUM FOR THE REALIZATION OF THE SOCIETY'S MISSION AND GOALS, THE IMPROVEMENT OF PATIENT CARE FOR THOSE WITH SPINAL DEFORMITIES. PRESENTATIONS AT THE ANNUAL MEETING & COURSE ARE GIVEN BY LEADING EXPERTS IN THE FIELD AND HAVE VALUE FOR HEALTH CARE PROFESSIONALS WHO TREAT SPINAL DEFORMITIES AT ALL LEVELS AND IN ALL AGES. OVER 100 PAPERS ARE PRESENTED ON AN ARRAY OF TOPICS, INCLUDING ADOLESCENT IDIOPATHIC SCOLIOSIS, GROWING SPINE, KYPHOSIS, ADULT DEFORMITY, TRAUMA, NEUROMUSCULAR SCOLIOSIS AND TUMORS. 344392 344392 SRS COLLABORATES WITH CORPORATE PARTNERS AND THE INTERNATIONAL SPINE STUDY GROUP ON THE ASLS II STUDY. THIS STUDY IS A CONTINATION OF THE ASLS I STUDY WHICH WAS A PROSPECTIVE, RANDOMIZED NIH FUNDED STUDY THAT EVALUATED THE 2 YEAR TREATMENT OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR ADULT PATIENTS WITH SYMPTOMATIC LUMBAR SCOLIOSIS. ASLS II ALLOWS FOR LONGER TERM FOLLOW UP OF THE PATIENTS IN THE STUDY. 874465 331659 650652 OTHER PROGRAM SERVICES: GLOBAL OUTREACH & WORLD WIDE COURSES; JOURNAL; TRAVELING FELLOWSHIP & SCHOLARSHIPS; RESEARCH; DIRECTED COURSES, SPINE DEFORMITY COURSES 874465 331659 650652 2112505 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 0 1 1 0 0 0 0 0 0 0 0 0 X 18 17 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 IL X EXECUTIVE DIRECTOR INC 4142766445 555 E WELLS ST STE 1100 MILWAUKEE WI 53202 X MARINUS DE KLEUVER MD PHD RESEARCH CHAIR 3.00 X 0 0 0 PETER O NEWTON MD PAST PRESIDENT 5.00 X X 0 0 0 PAUL D SPONSELLER MD MBA PAST PRESIDENT 7.00 X X 0 0 0 HEE-KIT WONG MD DIRECTOR 3.00 X 0 0 0 LAUREL C BLAKEMORE MD SECRETARY 7.00 X X 0 0 0 JUSTIN SMITH MD DIRECTOR 3.00 X 0 0 0 TODD J ALBERT MD PAST PRESIDENT 5.00 X X 0 0 0 BENNY DAHL MD DIRECTOR 3.00 X 0 0 0 LAWRENCE L HABER MD DIRECTOR 3.00 X 0 0 0 SERENA S HU MD TREASURER 7.00 X X 0 0 0 FERRAN PELLISE MD PHD DIRECTOR 3.00 X 0 0 0 JAMES O SANDERS MD DIRECTOR 3.00 X 0 0 0 SUKEN A SHAH MD EDUCATION CHAIR 3.00 X 0 0 0 RONALD A LEHMAN JR MD DIRECTOR 3.00 X 0 0 0 GREGORY M MUNDIS JR MD DIRECTOR 3.00 X 0 0 0 MUHARREM YAZICI MD PRESIDENT 3.00 X X 0 0 0 CHRISTOPHER I SHAFFREY MD PRESIDENT ELECT 5.00 X X 0 0 0 JOHN T SMITH MD DIRECTOR 3.00 X 0 0 0 0 0 0 0 0 0 0 EXECUTIVE DIRECTOR INC 555 E WELLS STREET STE 1100 MILWAUKEE WI 53202 MANAGEMENT 1103284 1 1267676 11577 1267676 ANNUAL MTNGS & WORKSHO 541900 512438 512438 MEMBERSHIP DUES & ASSE 541900 494030 494030 JOURNAL 541900 68611 68611 HOW FEES 541900 45000 45000 M&M REPORTS 541900 28150 28150 21000 21000 1169229 262971 262971 439540 0 439540 439540 439540 1182 0 1182 1182 ADVERTISING 541800 80500 72250 8250 OTHER REVENUE 541900 29010 29010 109510 3250108 1711211 8250 262971 546626 546626 5771 5771 125816 125816 1103284 726996 376288 82 82 11750 11750 73084 73084 31270 31270 5140 2014 3126 89042 64882 24160 51844 26991 24853 38159 37673 486 439547 345993 93554 6905 6905 21825 9040 12785 PRODUCTS AND PUBLICATIO 164757 164757 OTHER EXPENSES 11280 4849 6431 OUTREACH/TRAVELING FELL 10346 10346 MORBIDITY AND MORTALITY 2960 2960 4548 2576 1972 2744036 2112505 631531 0 2201067 1597001 505857 506307 20050 0 125793 754446 72840 72797 759004 533999 11425393 13073487 111473 700964 718236 15810968 17367746 94348 210156 290120 191390 384468 401546 X 14502273 15899706 924227 1066494 15426500 16966200 15810968 17367746 506072 1008164 25464 0 X 0 1 X 1 0 X 2245842 1939751 2500368 2495620 1761706 10943287 2245842 1939751 2500368 2495620 1761706 10943287 712188 10231099 122106 137442 245443 256432 262971 1024394 165500 225000 265000 259500 80500 995500 2421419 2442780 2641533 2628298 704209 10838239 23801420 3106 0.42990 0.39920 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER REVENUE - 2016 AMOUNT: $ 15,886. 2017 AMOUNT: $ 20,811. 2018 AMOUNT: $ 25,792. 2019 AMOUNT: $ 9,664. 2020 AMOUNT: $ 29,010. GROSS RECEIPTS FROM RELATED ACTIVITIES - 2016 AMOUNT: $ 2,405,533. 2017 AMOUNT: $ 2,421,969. 2018 AMOUNT: $ 2,615,741. 2019 AMOUNT: $ 2,618,634. 2020 AMOUNT: $ 675,199. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 0 X 4185188 1008164 1008164 3177024 73084 73084 3250108 2670952 0 2670952 73084 73084 2744036 PART V, LINE 4: RELYING ON PROFITS FROM MEETINGS AND DONATIONS FROM MEMBERS AND MEDICAL COMPANIES EACH YEAR, THE SRS BEGAN LIMITED RESEARCH FUNDING IN 1980. IN THE LATE 1980'S, SRS LEADERS DECIDED TO ESTABLISH A RESEARCH ENDOWMENT FUND IN ORDER TO GUARANTEE THE AVAILABLITY OF FUNDS FOR SCOLIOSIS RESEARCH. MOSTLY THROUGH DONATIONS FROM SRS MEMBERS, A GOAL OF $1.2 MILLION WAS REACHED IN 1992. INCOME FROM THIS FUND HAS BEEN USED EACH YEAR TO FUND PROJECTS SELECTED THROUGH A PEER-REVIEWED GRANT APPLICATION PROCESS. GRANT RECIPIENTS ARE REQUIRED TO PROVIDE REGULAR FINANCIAL REPORTS AND TO REPORT ON THE RESULTS OF THEIR RESEARCH AT AN SRS MEETING. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. HOWEVER, INCOME FROM CERTAIN ACTIVITIES (PRIMARILY ADVERTISING INCOME) NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. AS OF DECEMBER 31, 2020, THE ORGANIZATION HAD A TAX ASSET OF $20,205 FOR ESTIMATED PAYMENTS IN EXCESS OF ACTUAL UNRELATED BUSINESS INCOME TAX (UBIT). ESTIMATED TAX PAYMENTS AND PRIOR YEAR OVERPAYMENTS APPLIED TO 2020 TAX TOTALED $22,177. TOTAL UNRELATED BUSINESS INCOME TAX EXPENSE FOR THE YEAR ENDED DECEMBER 31, 2020, WAS $1,972. MANAGEMENT HAS REVIEWED ALL TAX POSITIONS RECOGNIZED IN PREVIOUSLY FILED TAX RETURNS IN THE U.S. FEDERAL AND STATE JURISDICTIONS AND THOSE EXPECTED TO BE TAKEN IN FUTURE TAX RETURNS. AS OF DECEMBER 31, 2020, THE ORGANIZATION HAD NO AMOUNTS RELATED TO UNRECOGNIZED INCOME TAX BENEFITS AND NO AMOUNTS RELATED TO ACCRUED INTEREST AND PENALTIES. THE ORGANIZATION DOES NOT ANTICIPATE ANY SIGNIFICANT CHANGES TO UNRECOGNIZED INCOME TAX BENEFITS OVER THE NEXT YEAR. 1 EAST ASIA & THE PACIFIC GRANTS TO RECIPIENTS LOCATED IN REGION 21800 EUROPE GRANTS TO RECIPIENTS LOCATED IN REGION 73766 SOUTH ASIA GRANTS TO RECIPIENTS LOCATED IN REGION 2750 NORTH AMERICA GRANTS TO RECIPIENTS LOCATED IN REGION 27500 SOUTH AMERICA PROGRAM SERVICES CURRENT CONCEPTS IN SPINE DEFORMITY 35849 0 0 0 0 0 0 161665 0 161665 EUROPE RESEARCH 19866 WIRE FMV EAST ASIA & THE PACIFIC RESEARCH 20000 WIRE FMV EUROPE RESEARCH 20000 WIRE FMV NORTH AMERICA RESEARCH 7500 WIRE FMV NORTH AMERICA RESEARCH 20000 WIRE FMV EUROPE RESEARCH 12000 WIRE FMV EUROPE RESEARCH 20000 WIRE FMV 7 0 0 0 0 0 0 0 PART I, LINE 2: WRITTEN APPLICATIONS SUBMITTED ARE REVIEWED BY THE RESEARCH GRANT OR AWARDS COMMITTEE. THOSE WHO RECEIVE RESEARCH GRANTS MUST ACKNOWLEDGE THAT THEY WILL SUBMIT WRITTEN PROGRESS AND FINANCIAL REPORTS AND THAT "IF FOR ANY REASON THE PROJECT FOR WHICH THE FUNDS WERE ALLOCATED CANNOT BE UNDERTAKEN WITHIN 12 MONTHS A FULL REFUND OF THE GRANT MONEY WILL BE MADE TO THE SRS," PRIOR TO DISTRIBUTION OF ANY FUNDS. SRS HAS A SPECIFIC GRANT REPORT FORM THAT IS TO BE COMPLETED AND COPIES OF THE GRANT REPORTS ARE KEPT IN SRS FILES. PART III ACCOUNTING METHOD: 1 RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK PO BOX 9 ALBANY NY 122010009 141368361 501(C)(3) 7500 FMV RESEARCH GRANT AMERICAN ACADEMY OF ORTHOPAEDIC SURGRONS 9400 W HIGGINS RD ROSEMONT IL 60018 362110592 501(C)(3) 15000 FMV BOARD OF SPECIALTY SOCIETIES SUPPORT STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 32000 FMV RESEARCH GRANT THE CHILDREN'S HOSPITAL CORPORATION 300 LONGWOOD AVENUE BOSTON MA 021155724 042774441 501(C)(3) 11838 FMV RESEARCH GRANT NEW YORK UNIVERSITY 70 WASHINGTON SQUARE SOUTH NEW YORK NY 10012 135562308 501(C)(3) 7500 FMV RESEARCH GRANT INTERNATIONAL SPINE STUDY GROUP FOUNDATION 15480 IOLA ST BRIGHTON CO 80602 271833811 501(C)(3) 344392 FMV ASLS II STUDY FUNDING MAYO CLINIC RESEARCH 200 FIRST STREET SW ROCHESTER MN 55902 416011702 501(C)(3) 5272 FMV RESEARCH GRANT ORTHOPAEDIC RESEARCH AND EDUCATION FOUNDATION 9400 W HIGGINS RD STE 215 ROSEMONT IL 600184975 366009467 501(C)(3) 42500 FMV SPINE COLLABORATIVE RESEARCH FUNDING STRAIGHT FORWARD SCOLIOSIS FOUNDATION INC 685 MONROE ST TOP FLOOR BROOKLYN NY 112212813 812827904 501(C)(3) 10000 FMV STRAIGHTFORWARD CAMPAIGN SUPPORT THE REGENTS OF THE UNIVERSITY OF COLORADO 1800 N GRANT ST STE 600 DENVER CO 80203 846000555 501(C)(3) 20000 FMV RESEARCH GRANT TRUSTEES OF COLUMBIA UNIVERSITY 622 W 113TH STREET NEW YORK NY 10025 135598093 501(C)(3) 35000 FMV RESEARCH GRANT WASHINGTON UNIVERSITY 660 S EUCLID AVE ST LOUIS MO 63110 430653611 501(C)(3) 7500 FMV RESEARCH GRANT 12 0 PART I, LINE 2: WRITTEN APPLICATIONS SUBMITTED ARE REVIEWED BY THE RESEARCH GRANT OR AWARDS COMMITTEE. THOSE WHO RECEIVE RESEARCH GRANTS MUST ACKNOWLEDGE THAT THEY WILL SUBMIT WRITTEN PROGRESS AND FINANCIAL REPORTS AND THAT "IF FOR ANY REASON THE PROJECT FOR WHICH THE FUNDS WERE ALLOCATED CANNOT BE UNDERTAKEN WITHIN 12 MONTHS A FULL REFUND OF THE GRANT MONEY WILL BE MADE TO THE SRS," PRIOR TO DISTRIBUTION OF ANY FUNDS. SRS HAS A SPECIFIC GRANT REPORT FORM THAT IS TO BE COMPLETED AND COPIES OF THE GRANT REPORTS ARE KEPT IN SRS FILES. FORM 990, PART III, LINE 2 AS A RESULT OF COVID-19 VARIOUS MEETINGS/COURSES WERE CANCELLED, POSTONED OR HELD VIRTUALLY RATHER THAN IN-PERSON. FORM 990, PART VI, SECTION A, LINE 3 LINE 3 EXPLANATION - SRS IS CONTRACTED WITH EXECUTIVE DIRECTOR, INC. (EDI) TO PROVIDE ASSOCIATION MANAGEMENT SERVICES. FORM 990, PART VI, SECTION A, LINE 6 LINE 6 EXPLANATION - SRS HAS SIX CLASSES OF MEMBERSHIP (REFERRED TO AS "FELLOWSHIP") NAMELY, CANDIDATE, ACTIVE, INACTIVE, ASSOCIATE, EMERITUS, AND HONORARY. FORM 990, PART VI, SECTION A, LINE 7A LINE 7A EXPLANATION - THE NOMINATING COMMITTEE PRESENTS A FINAL SLATE OF CANDIDATES TO THE SRS MEMBERSHIP AND THE CANDIDATES ARE ELECTED UPON RECEIVING A MAJORITY OF THE VOTES CAST BY ACTIVE FELLOWS AT THE ANNUAL MEETING. FORM 990, PART VI, SECTION A, LINE 7B LINE 7B EXPLANATION - THERE ARE THREE DECISIONS THAT REQUIRE A VOTE BY THE MEMBERS: ELECTION OF OFFICERS, REMOVAL OF AN OFFICER AND AMENDMENTS TO THE BYLAWS. ONLY ACTIVE MEMBERS IN GOOD STANDING MAY VOTE, AND THEY MUST VOTE IN PERSON AT THE ANNUAL MEETING OR AT A SPECIAL MEETING, IF ONE IS CALLED. ELECTION OF OFFICERS REQUIRES ONLY A SIMPLE MAJORITY. AMENDMENTS AND REMOVAL OF AN OFFICER REQURE A 2/3 MAJORITY OF THOSE PRESENT. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE BOARD OF DIRECTORS RECEIVES AND REVIEWS A COPY OF THE FORM 990 AND ALL APPLICABLE SCHEDULES. AFTER THE BOARD APPROVES OF THE FORM, IT IS SIGNED BY A SELECTED OFFICER AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C MANAGEMENT REVIEWS THE DISCLOSURE FORMS AND INFORMS THE BOARD OF ANY POSSIBLE CONFLICTS. THE FORMS ARE KEPT ON FILE AND AVAILABLE FOR THE BOARD OF DIRECTORS TO REVIEW. FORM 990, PART VI, SECTION B, LINE 15 SRS IS MANAGED BY EXECUTIVE DIRECTOR, INC., A FOR-PROFIT MANAGEMENT COMPANY. SRS HAS NO OFFICIAL EMPLOYEES BECAUSE ALL STAFF ASSIGNED TO SRS ARE EMPLOYEES OF THE MANAGEMENT COMPANY. SRS CONTRACTS WITH EXECUTIVE DIRECTOR, INC TO PROVIDE OFFICE FACILITIES, MANAGEMENT, RECORD KEEPING, ACCOUNTING, STORAGE, OTHER SIGNIFICANT SERVICES AND RELATED OVERCOST. THE ASSOCIATION MANAGEMENT FEE IS REVIEWED AT LEAST ONCE A YEAR BY THE BOARD, USUALLY DURING THE BUDGETING PROCESS FOR THE NEXT YEAR. SRS DOES NOT HAVE ANYBODY WHO FITS THE DEFINITION OF A KEY EMPLOYEE. REASONABLE COMPENSATION FOR SERVICES RENDERED TO OR FOR SRS TO OFFICERS IS ANNUALLY REVIEWED AND APPROVED BY THE BOARD DURING THE BUDGETING PROCESS. FORM 990, PART VI, SECTION C, LINE 19 SRS MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FORM 990/990-T AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. ALL REQUESTS SHOULD BE MADE TO THE SRS OFFICE AND A PRINT OR ELECTRONIC COPY OF THE REQUESTED DOCUMENTS WILL BE PROVIDED.